Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin (Q44923546)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Richard E Champlin

2

object named as

Champlin RE

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

4

object named as

Giralt SA

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Ghosh S

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Englund J

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Rolston K

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Raad I

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jacobson K

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Neumann J

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Ippoliti C

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Mallik S

10

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Whimbey E

11

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

751-755

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Respiratory syncytial virus infection in immunocompromised adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Respiratory syncytial virus infections in adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

An outbreak of respiratory syncytial virus in a bone marrow transplant center

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Community respiratory virus infections in immunocompromised patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Respiratory virus infections in bone marrow transplant recipients: the European perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Ribavirin aerosol in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Maternal antibody and respiratory syncytial virus infection in infancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

21 January 2018

Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702228

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702228

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

release_s4btrywoovgidbd3q4fmaoxtvq

1 reference

https://api.fatcat.wiki/v0/release/s4btrywoovgidbd3q4fmaoxtvq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44923546&oldid=2206992263"